Annual report for Jyothy Labs Ltd. for FY-2024
15-05-2024
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511-05-2024
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement issued pursuant to Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and Sample Reminder Letter sent to the Shareholders10-05-2024
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201508-05-2024
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation07-05-2024
Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for the quarter and year ended March 31, 202403-05-2024
Jyothy Labs Ltd - 532926 - Corporate Action-Board to consider Dividend
Notice is hereby given that a Meeting of the Board of Directors of Jyothy Labs Limited is scheduled to be held on Wednesday, May 15, 2024, to consider recommendation of dividend, if any, on the equity shares of the Company for the financial year 2023-24.03-05-2024
Jyothy Labs Ltd - 532926 - Board Meeting Intimation for For Considering And Approving The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024 And Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year 2023-24.
Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31, 2024 together with the Auditors' Reports thereon by the Statutory Auditors of the Company; and recommend dividend, if any, on the equity shares of the Company for the financial year 2023-24.03-05-2024
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-05-2024
Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201524-04-2024